2021 Marks Milestone Fourth Patient Choice Award for PANTHERx Rare
Read the Official PANTHERx Press Release.
PANTHERx Rare has again been recognized as the winner of the annual, national Specialty...
Read More
PANTHERx® Rare Pharmacy Selected by ChemoCentryx to Distribute TAVNEOS™ (avacopan) in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Read the Official PANTHERx Press Release.
PANTHERx Rare Pharmacy announces that it has been selected by ChemoCentryx as...
Read More
PANTHERx® Rare Pharmacy Selected by Rhythm Pharmaceuticals to Distribute IMCIVREE™ (setmelanotide) for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
Read the Official PANTHERx Press Release.
PANTHERx® Rare Pharmacy announced today that it was selected by Rhythm Pharmaceuticals...
Read More
Centene Signs Definitive Agreement to Acquire PANTHERx Rare Pharmacy (PANTHERx)
Today is a transformative day and the culmination of a great deal of effort and diligence to support the future of PANTHERx....
Read More
Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, Named an EY Entrepreneur Of The Year® 2020 National Award Winner
Read the Official PANTHERx Press Release.
Ernst & Young LLP (EY US) yesterday announced that Dr. Gordon J. Vanscoy, Chairman...
Read More
PANTHERx® Rare Pharmacy Selected by Blueprint Medicines to Distribute GAVRETO™ (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
Read the Official PANTHERx Press Release.
PANTHERx® Rare Pharmacy announces that it has been selected by Blueprint Medicines...
Read More
